Blood test to predict cervical cancer return after surgery
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial uses a simple blood test to look for cancer DNA (ctDNA) and HPV DNA after cervical cancer surgery. The goal is to detect any return of the cancer early, so you and your doctor can act quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HPV-positive cervical cancer (stages I–IV) and have not yet started treatment.
- You are 18 years old or older.
- You are expected to live at least 3 more months.
- You are willing to sign a consent form and give blood samples and medical information at each visit.
- You are not pregnant or breastfeeding.
- You are not taking part in any other clinical trials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with early-stage liver cancer who are scheduled for surgery. It uses a simple blood test to look for tiny bits of tumor DNA after treatment, which may help predict if the cancer will come back.
This study checks whether a simple blood test (called ctDNA) can predict if liver cancer will come back after surgery. It compares the blood test to a standard lab result from the removed tumor, which may help doctors plan better follow-up care.
This trial uses a simple blood test to check for signs of liver cancer coming back after surgery. It may help doctors catch a return earlier and guide further treatment.
This trial studies a blood test that looks for HPV DNA after cervical cancer surgery. The test may help doctors predict if the cancer might come back and decide if more treatment is needed.
This study uses a simple blood test to look for tiny bits of cancer DNA after your treatment. It aims to see if this test can help predict whether the cancer might come back.
This trial uses a special blood test to look for tumor DNA in your blood to monitor for cervical cancer recurrence and help guide treatment decisions. It may help your doctor know if your cancer is coming back and choose the best treatment options.
Hear when a new cfHPV DNA in Plasma of Cervical Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.